R
Remus Pharmaceuticals
722.20
NSE
R
Remus Pharmaceuticals
722.20
NSE
REMUS Fundamentals
Company Valuation
Market Cap (₹ Cr.)
851
PE Ratio
22.10
PB Ratio
3.33
Dividend Yield
0.07%
ROE
13.60%
ROCE
15.69%
Book Value (₹)
217.13
Face Value (₹)
10.00
Analyse REMUS with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2024 | Mar 2025 | Jul 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 70.84% | 70.85% | 70.85% | 70.91% | 70.95% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.83% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 5.28% |
| Public Investors | 20.49% | 19.18% | 18.90% | 18.78% | 18.50% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
REMUS Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
SME
BSE Scrip Code
0
NSE Scrip Name
REMUS
ISIN
INE0O5T01011



